JointMedica receive Continuity Support Grant for current Innovate UK funded projects
JointMedica receive Continuity Support Grant for current Innovate UK funded projects
JointMedica are set to benefit from a Continuity Support package, providing businesses with help to support projects which have been delayed and affected by the COVID-19 pandemic.
Monies were made available in continuity grants to SMEs and third sector organisations who are existing Innovate UK award holders to ensure the success and delivery of new innovation during the COVID-19 epidemic.
Terence Smith, Managing Director of JointMedica commented;
We are eternally grateful to the innovate UK organisation for their continued support of our development technologies. JointMedica can now continue with our work, striving towards our goals.
For further information visit www.innovateuk.gov.uk
Jointmedica was formed in 2000. Our history can be traced back to Midland Medical Technologies (MMT) and the creation of the Birmingham Hip Resurfacing™ (BHR™), the most clinically successful Hip Resurfacing of all time.
Our association with the BHR’s principle designing surgeons Prof Derek McMinn and Mr Ronan Treacy, along with the design and manufacturing consistency places JointMedica in an advantageous position relative to the unique understanding of Hip Resurfacing design, surgical procedure, and long-term functional results.
Our Mission
To sympathetically enhance the currently accepted Hip and Knee arthroplasty interventions, by creating implants which exhibit superior functionality, apply biomechanical sensitivity, and innovative form.
These principles allow for the delivery of products which improve the device function as opposed to simply altering it from standard.
Our Objective
To form a close relationships with key Orthopaedic Surgeons, empowering the creation of products that are highly innovative while at the same time meeting the heightened expectations of patients along with the stringent quality and safety standards that apply to modern orthopaedic implants.